期刊文献+

组织间隙注射Gd-PBCA纳米微粒鉴别良恶性淋巴结的实验研究

Differentiation of Metastatic from Benign Lymph Nodes with Interstitial Injection of Gd-PBCA Nanoparticles
下载PDF
导出
摘要 目的:制备Gd-DTPA聚氰基丙烯酸正丁酯纳米微粒(Gd-PBCA-NP),组织间隙注射Gd-PBCA-NP,评估其在良恶性淋巴结诊断和鉴别诊断中的价值。方法:采用阴离子乳化聚合法制备Gd-PBCA-NP,测定其粒径及分布、包封率及载药量,透射电镜观察其形态。选取健康成年新西兰白兔12只,采用随机数字法将其分为反应性增生淋巴结组及肿瘤转移淋巴结组2组。MRI平扫后2只反应性增生淋巴结于兔后脚掌注射后第1、3、6、12、24和48h点扫描,其余为给药后第24h扫描。测量淋巴结大小、平扫及增强后各组淋巴结信号强度并作统计学分析,观察增强后各组淋巴结MRI表现。结果:透射电镜观察Gd-PBCA-NP呈类圆形,大小均匀,表面平滑完整,粒子之间无粘连,具有明显的核-壳结构,其平均粒径65.7nm,粒径分布为0.09,平均包封率和载药量分别为81.97%、51.23%。反应性增生淋巴结和肿瘤转移性淋巴结均制作成功,平扫两组淋巴结在4个序列图像上的SNR、大小差异均无显著性意义。组织间隙注射Gd-PBCA-NP后,反应性增生淋巴结信号强度呈缓慢上升,于24h左右达到高峰,在T1WI、T1WI FS上表现为显著均匀强化,而肿瘤转移淋巴结表现为不均匀强化或无强化,两组SNR对比差异有显著性意义;在T2WI、T2*WI像上两组均未见强化,两组对比差异无显著性意义。结论:组织间隙注射Gd-PBCA-NP后,反应性淋巴结与肿瘤转移性淋巴结表现出不同的强化特征,在良恶性淋巴结鉴别中具有潜在的应用价值。 Objective: To prepare polybutyleyanoaerylate (PBCA) nanopartieles loaded with Gd-DTPA (Gd-PBCA- NP) and evaluate the effect in differentiation of metastatic from benign lymph nodes after interstitial injection of Gd-PBCA- NP. Methods:Gd-PBCA-NP were prepared by anionic emulsion polymerization. The size and encapsulation efficiency and loading capacity of Gd-PBCA-NP were measured. The morphology of Gd-PBCA-NP was examined by transmission electron microscopy. 12 New Zealand White Rabbits were divided into 2 groups at random: reactive hyperplasis group and tumorbearing group. All MR imaging was performed. Two animals were scanned at 1h, 3h, 6h, 12h,24h,48h but the others were scanned at 24h after injection of contrast agents. The signal intensity and size of all lymph nodes was measured on different sequences of images before and after contrast enhancement. The enhanced appearance of lymph nodes was observed in two groups. Results: The morphology of Gd-PBCA-NP was oval shaped with core-shell structure without adherence between particles observed by transmission electron microscopy. The average size of Gd-PBCA-NP was 65. 7nm and the index of size distribution was 0.09. The average encapsulation efficiency and loading capacity of Gd-PBCA-NP were respective 81.97 %, 51.23%. The reactive hyperplasia and metastatic lymph node models in all New Zealand White Rabbits were successfully developed. On unenhanced images,the SNR and the size of lymph nodes had no significant difference in four sequences of images in two groups. After interstitial injection of Gd-PBCA-NP, the SNR of the reactive hyperplasia lymph nodes increased slowly, and the maximal enhancement occurred at 24 hour. The reactive hyperplasia lymph nodes demonstrated obviously homogenous enhancement while metastatic lymph nodes showed heterogeneous or no enhancement, there were significant difference in the SNR of lymph nodes on enhanced T1WI and T1 WI with FS images, but no significant difference on T2 WI and T2 * WI images between two groups. Conclusion: After interstitial injection of Gd-PBCA-NP, metastatic lymph nodes showed different enhancing characteristics from those of reactive hyperplasia nodes and it has the potential value in differentiating metastatic from benign lymph nodes.
出处 《放射学实践》 2007年第10期1021-1025,共5页 Radiologic Practice
关键词 磁共振 对比剂 纳米结构 淋巴结 Magnetic resonance imaging Contrast media Nanostructures Lymph nodes
  • 相关文献

参考文献10

  • 1Friese A,Seiller E,Quack G,et al.Increase of the Duration of the Anticonvulsive Activity of a Novel NMDA Receptor an Tagonist Using Poly (butylcyanoacrylate) Nanoparticles as a Parenteral Controlled Release System[J].Eur J Pharm Biopharm,2000,49(1):103-109.
  • 2Kreuter J.Nanoparticulate Systems for Brain Delivery of Drugs[J].Adv Drug Deliv Rev,2001,47(1):65-81.
  • 3AC de Verdiere,Dubernet C,Nemati F,et al.Reversion of Multidrug Resistance with Polyalkylcyanoacrylate Nanoparticles:Towards a Mechanism of Action[J].Br J Cancer,1997,76 (1):198-205.
  • 4Michel SC,Keller TM,Frohlich JM,et al.Preoperative Breast Cancer Staging:MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement[J].Radiology,2002,225(2):527-536.
  • 5Yoshimi A,Catherine W,Piccoli M,et al.Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10 Enhanced MR Imaging:Phase Ⅲ Safety and Efficacy Study[J].Radiology,2003,228(3):777-788.
  • 6吴元魁,许乙凯,黄其鎏.超顺磁氧化铁粒子增强MRI区分肿瘤转移性与良性淋巴结的实验研究[J].中华放射学杂志,2002,36(6):562-566. 被引量:14
  • 7Oussoren C,Zuidema J,Crommelin G,et al.Lymphatic Uptake and Biodistribution of Liposomes after Subcutaneous Injection.Ⅱ.Influence of Liposomal Size,Lipid Composition and Lipid Dose,Biochim[J].Biophys Acta,1997,7 (2):227-240.
  • 8Misselwitz B,Platzek J,Weinmann HJ.MR Lymphography after Interstitial Injection of Contrast Media[J].Lymphology,1998,31(2):326 -329.
  • 9罗德红,石木兰,徐震纲,姚迪冬,吴宁,郝玉芝.颈部转移淋巴结的CT、B超扫描与临床触诊对比分析[J].中华肿瘤杂志,1998,20(1):48-50. 被引量:39
  • 10Misselwitz B,Platzek J,Weinmann H J,et al.Early MR Lymphography with Gadofluorine M in Rabbits[J].Radiology,2004,231(3):682-688.

二级参考文献4

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部